hVIVO (LON:HVO) Trading Down 6.8% – Should You Sell?

hVIVO plc ( LON:HVO – Get Free Report ) shares traded down 6.8% during mid-day trading on Friday . The stock traded as low as GBX 19 ($0.

24) and last traded at GBX 19.10 ($0.24).



2,518,262 shares traded hands during mid-day trading, a decline of 26% from the average session volume of 3,389,765 shares. The stock had previously closed at GBX 20.50 ($0.

25). hVIVO Stock Performance The stock’s 50 day moving average is GBX 23.20 and its 200-day moving average is GBX 26.

66. The company has a market cap of £129.95 million, a P/E ratio of 636.

67 and a beta of 0.97. The company has a current ratio of 1.

61, a quick ratio of 1.16 and a debt-to-equity ratio of 33.86.

About hVIVO ( Get Free Report ) hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations.

The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model. Read More Five stocks we like better than hVIVO Investing in Construction Stocks Quantum Opportunity: Skywater Technology’s Long-Term Potential High Flyers: 3 Natural Gas Stocks for March 2022 Nebius Group: The Rising Star in AI Infrastructure Insider Selling Explained: Can it Inform Your Investing Choices? MarketBeat Week in Review – 12/30 – 1/03 Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter .

.